期刊文献+

狼疮肾炎患者高尿酸血症患病率及其危险因素分析 被引量:8

Prevalence and risk factors of hyperuricemia in patients with lupus nephritis
原文传递
导出
摘要 目的 了解本院狼疮肾炎(LN)患者高尿酸血症的患病率及其相关危险因素.方法 回顾性分析1998年1月至2010年12月于中山大学附属第一医院确诊为LN的959例患者的临床及病理特征.采用多因素Logistic回归分析LN患者高尿酸血症发生的影响因素.结果 本研究LN患者中,高尿酸血症的患病率为57.7%,其中CKD1~5期各期患者高尿酸血症的患病率分别为44.1%、65.7%、74.7%、77.6%、73.9%.LN患者伴发高尿酸血症的独立危险因素为血三酰甘油水平的升高及内皮细胞增生(≥50%);肾损害早期(CKD1~2期)LN患者伴发高尿酸血症的独立危险因素为血三酰甘油水平升高;肾损害中晚期(CKD3~5期)LN患者伴发高尿酸血症的独立危险因素为dsDNA阳性及抗心磷脂抗体IgM阳性.结论 本研究中LN患者高尿酸血症的患病率为57.7%,LN患者包括肾损害早期患者高尿酸血症发生与血三酰甘油密切相关,提示LN患者高尿酸血症的发生与代谢紊乱密切相关. Objective To investigate the prevalence and related risk factors of hyperuricemia in patients with lupus nephritis (LN) in Southern China.Methods A single center retrospective study,959 adult LN patients diagnosed with biopsy-proven,who admitted to The First Affiliated Hospital,Sun Yat-sen University from 1998.01 to 2010.12 were recruited.Results Among this cohort,the prevalence of hyperuricemia was 57.7%.The prevalence of hyperuricemia for CKD stage 1,2,3,4,5 was 44.1%,65.7%,74.7%,77.6%,73.9%,respectively.Logistic regression analysis showed that increased serum triglyceride level and endothelial proliferation (≥50%) were independent risk factors of hyperuricemia in LN patients; Also,increased serum triglyceride level was an independent risk factor of hyperuricemia in LN patients of CKD stage 1-2; Positive dsDNA and positive anticardiolipin antibody were independent risk factors of hyperuricemia in LN patients of CKD stage 3-5.Conclusion The prevalence of hyperuricemia in LN patients from this cohort is 57.7%.Increased level of serum triglyceride is an independent risk factor associated with hyperuricemia in both overall LN patients and those of CKD stages 1-2.Therefore,the present study indicates that metabolic factors may influence each other,and should be paid more attention in the clinical practice of LN care.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2014年第11期805-812,共8页 Chinese Journal of Nephrology
基金 “十二五”国家科技支撑计划(2011BAI10B05) 中山大学5010项目(2007007)
关键词 狼疮肾炎 高尿酸血症 患病率 危险因素 Lupus nephritis Hyperuricemia Prevalence Risk factor
  • 相关文献

参考文献15

  • 1Weiner DE,Tighiouart H,Elsayed EF,et al.Uric acid and incident kidney disease in the community[J].J Am Soc Nephrol,2008,19:1204-1211.
  • 2Obermayr RP,Temml C,Gutjahr G,et al.Elevated uric acid increases the risk for kidney disease[J].J Am Soc Nephrol,2008,19:2407-2413.
  • 3Chonchol M,Shlipak MG,Katz R,et al.Relationship of uric acid with progression of kidney disease[J].Am J Kidney Dis,2007,50:239-247.
  • 4Madero M,Sarnak MJ,Wang X,et al.Uric acid and long-term outcomes in CKD[J].Am J Kidney Dis,2009,53:796-803.
  • 5Chen W,Chen W,Wang H,et al.Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China[J].Nephrol Dial Transplant,2009,24:1205-1212.
  • 6梁孟君,欧姆,陈绪敏,张望,陈崴,杨琼琼,毛海萍,余学清.IgA肾病患者高尿酸血症患病率及其相关危险因素分析[J].中华肾脏病杂志,2013,29(5):326-332. 被引量:27
  • 7Shi Y,Chen W,Jalal D,et al.Clinical outcome of hyperuricemia in IgA nephropathy:a retrospective cohort study and randomized controlled trial[J].Kidney Blood Press Res,2012,35:153-160.
  • 8Feig DI,Kang DH,Johnson RJ.Uric acid and cardiovascular risk[J].N Engl J Med,2008,359:1811-1821.
  • 9Zhang L,Wang F,Wang L,et al.Prevalence of chronic kidney disease in China:a cross-sectional survey[J].Lancet,2012,379 (9818):815-822.
  • 10National Kidney Foundation.K/DOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification[J].Am J Kidney Dis,2002,39 (2 Suppl 1):S1-S266.

二级参考文献15

  • 1Donadio JV, Grande JP. IgA nephropathy. N Engl J Med,2002,347: 738-748.
  • 2Le W, Liang S, Hu Y, et al. Long - term renal survival andrelated risk factors in patients with IgA nephropathy: resultsfrom a cohort of 1155 cases in a Chinese adult population.Nephrol Dial Transplant, 2012, 27: 1479-1485.
  • 3Kang DH, Chen W. Uric acid and chronic kidney disease: newunderstanding of an old problem. Semin Nephrol, 2011,31:447-452.
  • 4Syrjanen J, Mustonen J, Pasternack A. Hypertriglyceridaemiaand hyperuricaemia are risk factors for progression of IgAnephropathy. Nephrol Dial Transplant, 2000, 15: 34-42.
  • 5Ohno I, Hosoya T, Gomi H, et al. Serum uric acid and renalprognosis in patients with IgA nephropathy. Nephron, 2001,87: 333-339.
  • 6Shi Y, Chen W, Jalal D, et al. Clinical outcome ofhyperuricemia in IgA nephropathy: a retrospective cohort studyand randomized controlled trial. Kidney Blood Press Res,2012,35: 153-160.
  • 7Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascularrisk. N Engl J Med, 2008, 359: 1811-1121.
  • 8Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidneydisease in China: a cross - sectional survey. Lancet, 2012,379:815-822.
  • 9National Kidney Foundation. K/DOQI clinical practiceguidelines for chronic kidney disease: evaluation,classification, and stratification. Am J Kidney Dis, 2002, 39:S1-S266.
  • 10Chen W, Wang H, Dong X, et al. Prevalence and risk factorsassociated with chronic kidney disease in an adult populationfrom southern China. Nephrol Dial Transplant, 2009, 24: 1205-1212.

共引文献26

同被引文献75

  • 1陈香美,吴镝.尿酸性肾病[J].中华内科杂志,2005,44(3):231-233. 被引量:59
  • 2庄永泽,余英豪,郑智勇,陈建,谢福安.狼疮性肾炎活动性指数和慢性指数的临床意义[J].肾脏病与透析肾移植杂志,1996,5(5):22-26. 被引量:9
  • 3Ortega LM, Schultz DR, Lenz O, et al. Review: lupus nephritis:pathologic features, epidemiology and a guide to therapeuticdecisions[J]. Lupus, 2010, 19(5): 557-574.
  • 4Yang Z, Liang Y, Xi W, et al. Association of serum uric acid withlupus nephritis in systemic lupus erythematosus[J]. Rheumatol Int,2011, 31(6): 743-748.
  • 5陈灏珠, 钟南山, 陆再英, 等. 内科学[M]. 8 版. 北京: 人民卫生出版社, 2013: 790-794.
  • 6Chen W, Chen W, Wang H, et al. Prevalence and risk factorsassociated with chronic kidney disease in an adult population fromsouthern China[J]. Nephrol Dial Transplant, 2009, 24(4): 1205-1212.
  • 7Madero M, Sarnak MJ, Wang X, et al. Uric acid and long-termoutcomes in CKD[J]. Am J Kidney Dis, 2009, 53(5): 796-803.
  • 8Obermayr RP, Temml C, Gutjahr G, et al. Elevated uric acid increasesthe risk for kidney disease[J]. J Am Soc Nephrol, 2008, 19(12):2407-2413.
  • 9Ohno I. Relationship between hypertension and chronic kidneydiseases[J]. Nucleosides Nucleotides Nucleic Acids, 2011, 30(12):1039-1044.
  • 10Jaramillo M, Godbout M, Naccache PH, et al. Signaling eventsinvolved in macrophage chemokine expression in response tomonosodium urate crystals[J]. J Biol Chem, 2004, 279(50):52797-52805.

引证文献8

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部